Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (6): 65-70.doi: 10.6040/j.issn.1671-7554.0.2019.1198

Previous Articles    

CT-guided 125I seeds implantation for the treatment of malignant retroperitoneal tumor: an analysis of 55 cases

WANG Hao, LU Jian, CHEN Li, ZHA Junhao, GUO Jinhe   

  1. Center of Interventional Radiology &
    Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, Jiangsu, China
  • Published:2022-09-27

PDF (PC)

78

Abstract: Objective To evaluate the efficacy and safety of CT-guided 125I seeds implantation for the treatment of retroperitoneal malignant tumors. Methods A total of 55 patients with 69 lesions, which were unresectable, postoperative recurrent or metastatic, received 125I seeds implantation under CT guidance. CT scan was performed within 1 week before the implantation. The contour of tumor target area was outlined with the treatment planning system, and the required radiation dose, number of seeds and spatial arrangement were calculated. Then CT-guided 125I seeds implantation was performed. Follow-up was carried out at an interval of 2 month to evaluate the disease control rate, pain relief rate and treatment-related adverse events. Results All operations were successful. CT images 2 months after implantation showed complete response, partial response, stable disease and progressive disease in 9, 18, 36 and 6 lesions, respectively. The overall response rate was 39.1%, and local control rate was 91.3%. The overall response rate was 40.6% and 37.7%, and local control rate was 89.9% and 87.0%, respectively, 4 and 6 months after operation. In the 24 patients who had back or abdominal pain,12(50%)cases were relieved 7 days after the implantation. No treatment-related death occurred. Pain at puncture site was observed in 15 patients(27.3%), and only 1 patient need analgesic treatment to relieve. No complications, such as bleeding, intestinal fistula, radiation enteritis, or bone marrow suppression, were observed. Conclusion CT-guided 125I seeds implantation is safe and effective for the treatment of malignant retroperitoneal tumors. For patients with unresectable, postoperative recurrent or metastatic retroperitoneal tumors, CT-guided 125I seeds implantation may be a salvage strategy.

Key words: Retroperitoneal tumor, Iodine-125 radioactive seed, Interventional radiology, Tumor intervention, Brachytherapy

CLC Number: 

  • R815
[1] 中华医学会数字医学分会, 中国研究型医院学会数字医学临床外科专业委员会. 腹膜后肿瘤三维可视化精准诊治专家共识(2018版)[J]. 中国实用外科杂志, 2018,38(12):1347-1353.
[2] 辛世杰, 段力仁. 累及髂血管的腹膜后肿瘤的处理[J]. 中华血管外科杂志, 2018,3(3):137-140.
[3] Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution[J]. Ann Surg, 1998, 228(3):355-365.
[4] Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society(ABS)recommendations for transperineal permanent brachytherapy of prostate cancer[J]. Int J Radiat Oncol Biol Phys, 1999, 44(4):789-799.
[5] 杜思韵, 付平, 盖保东, 等. 超声引导下经皮穿刺植入放射性125I粒子治疗腹部恶性肿瘤[J]. 中华医学超声杂志(电子版), 2019,16(2):142-146. DU Siyun, FU Ping, GAI Baodong, et al. Ultrasound-guided interstitial implantation of iodine-125 seeds for treatment of malignant abdominal tumors[J]. Chinese Journal of Medical Ultrasound(Electronic Edition), 2019, 16(2): 142-146.
[6] 姜玉良, 吉喆, 田素青, 等. CT引导下125I粒子挽救性治疗头颈部复发/转移癌的临床疗效[J]. 中华医学杂志, 2018,98(45):3686-3691. JIANG Yuliang, JI Zhe, TIAN Suqing, et al. CT-guidance interstitial Iodine-125 seed brachytherapy as a salvage therapy for recurrent head and neck carcinoma[J]. National Medical Journal of China, 2018, 98(45): 3686-3691.
[7] Du P, Xiao Y, Lu W. Modified fan-shaped distribution technology for computed tomography(CT)-guided radioactive seed implantation in lung cancer patients with lung dysfunction[J]. Med Sci Monit, 2017, 23:4366-4375. doi:10.12659/MSM.902105.
[8] Han Q, Deng M, Lv Y, et al. Survival of patients with advanced pancreatic cancer after iodine125 seeds implantation brachytherapy: A meta-analysis[J]. Medicine(Baltimore), 2017, 96(5):e5719.
[9] Galego P, Silva FC, Pinheiro LC. Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?[J]. Int Braz J Urol, 2015, 41(2):353-359.
[10] 娄成, 钱建新, 顾小强, 等. 125I粒子植入治疗盆腔及后腹膜肿瘤23例分析[J]. 介入放射学杂志, 2016,25(7):631-634. LOU Cheng, QIAN Jianxin, GU Xiaoqiang, et al. 125I seed implantation for the treatment of pelvic and retroperitoneal malignant tumor: clinical analysis of 23 patients[J]. Journal of Interventional Radiology, 2016, 25(7): 631-634.
[11] 何闯, 刘云, 杨丽, 等. CT引导下125I粒子植入治疗腹膜后淋巴结转移瘤[J]. 介入放射学杂志, 2014,23(11):1022-1025. HE Chuang, LIU Yun, YANG Li, et al. CT-guided radioactive 125I seeds implantation therapy for retroperitoneal lymph node metastasis[J]. Journal of Interventional Radiology, 2014, 23(11):1022-1025.
[12] Zuo CJ, Wang PJ, Shao CW, et al. CT-guided percutaneous ethanol injection with disposable curved needle for treatment of malignant liver neoplasms and their metastases in retroperitoneal lymph nodes[J]. World J Gastroenterol, 2004,10(1):58-61.
[13] Zighelboim I, Ramirez PT, Gao F, et al. Retroperitoneal lymph node resection in patients with cervical cancer[J]. Surg Oncol, 2006,15(2):79-83.
[14] Langley SE, Laing R. Prostate brachytherapy has come of age: a review of the technique and results[J]. BJU Int, 2002,89(3):241-249.
[15] Blasko JC, Mate T, Sylvester JE, et al. Brachytherapy for carcinoma of the prostate: techniques, patient selection, and clinical outcomes[J]. Semin Radiat Oncol, 2002,12(1):81-94.
[16] Yao L, Jiang Y, Jiang P, et al. CT-guided permanent 125I seed interstitial brachytherapy for recurrent retroperitoneal lymph node metastases after external beam radiotherapy[J]. Brachytherapy, 2015, 14(5):662-669.
[17] Wang Z, Lu J, Gong J, et al. CT-guided radioactive 125I seed implantation therapy of symptomatic retroperitoneal lymph node metastases[J]. Cardiovasc Intervent Radiol, 2014, 37(1):125-131.
[18] 姚红响, 陈根生, 徐磊, 等. CT引导下同轴法125I粒子植入治疗腹膜后淋巴结转移瘤21例[J]. 介入放射学杂志, 2014,23(1):42-45. YAO Hongxiang, CHEN Gensheng, XU Lei, et al. CT-guide coaxial 125I seeds implantation for the treatment of retroperitoneal lymph node metastasis: analysis of 21 cases[J]. Journal of Interventional Radiology, 2014, 23(1):42-45.
[19] 王娟, 吴娟, 魏东, 等. CT引导下125I粒子植入治疗腹膜后淋巴结转移癌18例的初步疗效[J]. 介入放射学杂志, 2015, 24(3):219-222. WANG Juan, WU Juan, WEI Dong, et al. The efficacy of CT-guided radioactive 125I seed implantation for retroperitoneal lymph node metastases: preliminary evaluation of 18 cases[J]. Journal of Interventional Radiology, 2015, 24(3):219-222.
[20] 汪建华, 左长京, 邵成伟, 等. CT引导下125Ⅰ粒子植入治疗腹部淋巴结转移癌的临床应用[J]. 介入放射学杂志, 2011,20(11):877-881. WANG Jianhua, ZUO Changjing, SHAO Chengwei, et al. CT-guided 125I seed brachytherapy forabdominal metastatic lymphnodes[J]. Journal of Interventional Radiology, 2011, 20(11):877-881.
[21] 林琦, 张颖, 袁苑, 等. 肾上腺转移瘤放射性125I粒子植入治疗后胃穿孔1例[J]. 山东大学学报(医学版), 2017,55(7):124-129.
[22] 郭金友, 郑家平, 费伦. CT引导下125I粒子植入治疗合并癌痛难治性恶性肿瘤[J]. 介入放射学杂志, 2016,25(2):141-144. GUO Jinyou, ZHENG Jiaping, FEI Lun. CT-guided 125I implantation for the treatment of refractory malignant tumorcompaniedwith cancerous pain[J]. Journal of Interventional Radiology, 2016, 25(2):141-144.
[23] 张亮, 黄子林, 张福君, 等. CT导向下介入125Ⅰ粒子置入联合化学消融治疗腹膜后恶性肿瘤[J]. 中华放射学杂志, 2008,42(9):969-973. ZHANG Liang,HUANG Zilin,ZHANG Fujun, et al. CT-guided 125I radioactive seeds Implantation and chemical ablation for malignant retroperitonealtumor[J]. Chinese Journal of Radiology, 2008, 42(9): 969-973.
[24] Kim JH. Comparison of the EORTC criteria and PERCIST in solid tumors: a pooled analysis and review[J]. Oncotarget, 2016, 7(36):58105-58110.
[25] 马潞娜, 李立伟, 王骁. 105例恶性肿瘤125I粒子治疗后18F-FDGPET/CT影像分析[J]. 实用医学杂志, 2015,31(6):956-958.
[26] Suzuki C, Jacobsson H, Hatschek T, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations[J]. Radiographics, 2008, 28(2):329-344.
[1] DI Xuemin, NIU Shulei, ZHAO Jing, DU Sui, YU Huimin, ZHANG Hongtao, WANG Juan. CT-guided 125I seed implantation for lymph node metastases in patients with gastric cancer of later stage [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 79-84.
[2] CAO Qianqian, JIANG Yuhua, LI Yuliang, YANG Ruijie, LIU Lu, ZHANG Xile, WANG Junjie. A dosimetric analysis of cervical metastases between radioactive 125I seeds implantation and external beam radiation therapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 55-60.
[3] LI Yang, HE Chuang, CHEN Yuxiao, YANG Li, LI Liangshan, LI Tingyuan, HUANG Xuequan. CT-guided interstitia 125I seed implantation in the treatment of long bone metastasis: a primary clinic study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 50-54.
[4] DAI Jianjian, YUAN Bing, ZHANG Ying, LIN Qi, YUAN Yuan, HAN Mingyong. CT-guided percutaneous 125I seed implantation brachytherapy in patients with stage Ⅲ non-small-cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 32-37.
[5] HUO Bin, WANG Lei, WANG Haitao, HUO Xiaodong, CAO Qiang, WANG Lili, ZANG Li, WANG Jinhuan, ZHENG Guanjun, CHAI Shude. Feasibility of radioactive seed implantation in the treatment of lung cancer assisted by template combined with rib drilling technique [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 26-31.
[6] CHAI Shude. Current status and technical innovation of radioactive seed brachytherapy in the treatment of bronchial lung cancer in China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 4-7.
[7] SHEN Wenjiang. Radioactive seeds implantation in tumor treatment [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 1-3.
[8] FANG Hai-yang, XIANG Jian ,WU Yan-qing. Meta-analysis of drug-eluting stents implantation versus vascular brachytherapy for in-stent restenosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(1): 56-63.
[9] WANG Xu-fu1，2， HAN Jian-kui1， LIU Xin-feng3， WANG Zhi-qiang1, SUN Jian-Wen1, ZUO Shu-yao2, YANG Guang-jie2. 125I seed implantation in rabbit VX2 liver tumor: evaluation of
therapeutic effects and damage to normal liver tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 30-33.
[10] WANG Jing,LI Zhen-jia,WANG Xian-feng,MING De-guo,CHI Xiang-yu. Brachytherapy by CTguided percutaneous paracentesis implantation of iodine125 seeds for lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(10): 1017-1020.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd